“Unconventional” neutralizing activity of antibodies against HIV |
| |
Authors: | Michael Wen Hui Yang Paul Zhou |
| |
Institution: | (1) Laboratory of Anti-viral Immunity and Genetic Therapy, Institute Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, 200025, China |
| |
Abstract: | Neutralizing antibodies are recognized to be one of the essential elements of the adaptive immune response that must be induced
by an effective vaccine against HIV. However, only a limited number of antibodies have been identified to neutralize a broad
range of primary isolates of HIV-1 and attempts to induce such antibodies by immunization were unsuccessful. The difficulties
to generate such antibodies are mainly due to intrinsic properties of HIV-1 envelope spikes, such as high sequence diversity,
heavy glycosylation, and inducible and transient nature of certain epitopes. In vitro neutralizing antibodies are identified using “conventional” neutralization assay which uses phytohe-magglutinin (PHA)-stimulated
human PBMCs as target cells. Thus, in essence the assay evaluates HIV-1 replication in CD4+ T cells. Recently, several laboratories including us demonstrated that some monoclonal antibodies and HIV-1-specific polyclonal
IgG purified from patient sera, although they do not have neutralizing activity when tested by the “conventional” neutralization
assay, do exhibit potent and broad neutralizing activity in “unconventional” ways. The neutralizing activity of these antibodies
and IgG fractions is acquired through post-translational modifications, through opsonization of virus particles into macrophages
and immature dendritic cells (iDCs), or through expression of antibodies on the surface of HIV-1-susceptible cells. This review
will focus on recent findings of this area and point out their potential applications in the development of preventive strategies
against HIV.
Foundation item: Chinese Ministry of Science and Technology 973 program grant awarded to Paul Zhou (2006CB504308). |
| |
Keywords: | Antibody Neutralizing activity Human immunodeficiency virus (HIV) |
本文献已被 SpringerLink 等数据库收录! |
|